The Transcription Factor-Directed Therapies Summit brings together the leading innovative decision makers in molecular oncology, working to develop safe and effective therapeutic interventions.

This is your opportunity to communicate your products and services, elevate your brand and demonstrate your expertise in the following areas this growing field.

Clinical Development - position yourself as the leading Clinical Research organization in the space to accelerate and support clinical development

Preclinical Modelling – PDX, Syngeneic and Humanized models are critical to the timely advancement of these novel therapeutics - share what your models offer to improve the quality of preclinical research

Target Discovery – showcase your capabilities to boost the early development of immune-oncology therapies

Regulation – display your regulatory expertise to support developers in their efforts

 

To find out more about out bespoke partnership options and how they can support your business goals for 2022, contact us here.